Note to NIH Grant Recipients: Authors who are accepted for publication in the Journal of Stroke and Cerebrovascular
Diseases after May 2, 2005 may indicate that they wish to meet the NIH request for public access to their manuscript by sending
an e-mail to NIHauthorrequest@elsevier.com. Elsevier will subsequently send the author's manuscript incorporating changes
made during the peer review process to PubMed Central and authorize its posting 12 months after final publication.
Editors:
José Biller, MD, FACP, FAAN, FAHA Journal of Stroke and Cerebrovascular Diseases
Loyola University Chicago
Stritch School of Medicine
Department of Neurology, Bldg. 105
2160 S. 1st Avenue
Maywood, IL 60153
Shinichiro Uchiyama,
MD, PhD, FAHA
The Japan Stroke Society
4F Maruishi Building
1-10-4 Kaji-cho Chiyoda-ku
Tokyo 101-0044 Japan
The goal
of the Journal of Stroke and Cerebrovascular Diseases is to provide its readership with the highest quality material possible
through a process of careful peer review and editorial comment. The Journal seeks to publish original papers on basic and clinical science
related to the fields of stroke and cerebrovascular disease including review articles, controversies, methods and technical notes, selected
case reports, and other original articles of a special nature. Our editorial mission is to focus on prevention and management of cerebrovascular
disease. Thus, the scientific disciplines welcomed for publication will span from epidemiology to rehabilitation medicine. A new mission
will be to publish experimental studies from the test tube to the in vivo model whenever these approaches are applied to an understanding
of the mechanisms of injury or repair of the brain and its circulation. The Journal will emphasize the physiopathology and molecular
mechanisms of ischemia and hemorrhagic cell damage. Clinical papers will emphasize medical and surgical aspects of stroke, clinical trials
and design, epidemiology, stroke care delivery systems and outcomes, imaging sciences, and rehabilitation of stroke.
The Journal
of Stroke and Cerebrovascular Diseases now uses a web-based online manuscript submission and review system. Please go to http://ees.elsevier.com/jscvd
to submit your manuscript electronically. The website guides authors stepwise through the creation and uploading of the various files.
All correspondence, including the Editor's decision and request for revisions, will be by e-mail. Authors may send queries concerning
the submission process, manuscript status, or journal procedures to the Editorial Office at JSCVD@lumc.edu. Authors unable
to submit an electronic version should contact the Editorial Office to discuss alternatives. Authors must guarantee that once their
material has been accepted for publication by the Journal, they will not submit the same material or portions thereof to another journal
before publication in the Journal of Stroke and Cerebrovascular Diseases.
Any manuscripts determined to be improperly prepared
or edited can be returned to the authors without review.
All authors should adhere to the following instructions for submission of
manuscripts to the Journal of Stroke and Cerebrovascular Diseases.
Cover letter
The author(s) should provide
the aforementioned written assurances. In addition, author(s) are welcomed to suggest three to five referees for their paper (please
include e-mail addresses). However, the Editors cannot guarantee assignment of a particular reviewer to a paper. Any unusual circumstances
surrounding the research or explanations for deviations from standard procedures or format should be explained in the cover letter.
Manuscript preparation
Authors should submit manuscripts electronically, uploading documents to the submission website
(http://ees.elsevier.com/jscvd ). The system will convert documents to PDF files. Authors are encouraged to submit manuscripts
in Microsoft Word.
The Author
Agreement form (pdf) must accompany all submissions. Please scan the signed form and upload it with your online
submission.
Abbreviations
When using abbreviations, write the full name of the abbreviated item followed by the abbreviation
in parentheses at the point of first mention within the body of the manuscript. Do not use abbreviations in the abstract or title of
the manuscript.
Title page
The title page should contain the following information: (1) The full title of the manuscript,
not to exceed 120 characters. (2) The full names of all authors. Authors should be limited to those individuals who contributed in an important manner to the study design, data collection and analysis, or writing of the paper. (3) The department and institution where
work was performed, as well as the affiliations of the individual authors. (4) Grant support. (5) Name, address, and phone and fax numbers,
and e-mail address of the author to whom communications regarding the manuscript should be directed. (6) A shortened version of the title
that is 45 characters or less to be used as a running title.
Abstract
The abstract is limited to 250 words. Do not
use abbreviations, footnotes, or references in the body of the abstract. Include a brief description of the goal, materials and methods,
findings, and conclusion of the study.
Introduction, materials and methods, results, and discussion
Include within
the body of the text a description of the ethical guidelines that were followed for human and animal studies. If appropriate, provide
citation of institutional review by human or animal research committees. Also describe any hazardous procedures or chemicals involved
in the studies and what precautions were taken to avoid injury to subjects or investigators. Within the Materials and Methods section,
provide a brief but complete description of the statistical methods used, including which tests were used for analysis of which variables.
Drugs, medications, or other material should be listed as generic items. If brand names are used, they should be placed after the generic
name in parentheses with the manufacturer's name, city, and state or country.
Restrict all comments and discussion to the Discussion
section. Results presented in the Results section should not be repeated in the Discussion section.
References
Cite
references in text in order of appearance using Arabic numerals in parentheses for citations. Place the reference list at the end of
the final text page. References should be listed in text citation number order and must be double spaced. Include the names of all authors
up to a total of three before resorting to the use of "et al." All published material, including brief communications and letters to
the editor, must be cited in the References section. References to unpublished material, such as personal communications and unpublished
data, must be placed within the text and not cited in the References section. Personal communications and unpublished data must include
the individual's name, location, and month and year of communication as appropriate. In the reference list, use only abbreviations approved
for use in the latest edition of Index Medicus and conform style and punctuation to the requirements listed below:
Journal article:
Bontia R, Ford MA, Stewart AW. Predicting survival after stroke: A three-year follow-up. Stroke 1988;19:669-673.
Book chapter:
Whyte J, Robinson KM. Pharmacologic management. In: Glenn MB, Whyte J, eds. The practical management of spasticity in children and
adults. Philadelphia: Lea & Febiger, 1990:201-226.
Complete book:
Brooks VB. The neural basis of motor control.
New York: Oxford University Press, 1986.
Special type of article:
Schmidt R, Fazekas F, Horner S, et al. Lipoprotein
(a) serum levels of normals are not associated with carotid atherosclerosis and microangiopathy-related cerebral damage. J Stroke Cerebrovasc
Dis 1995;5:116 (abstr).
Tables
Tables must be cited in text and numbered according to order of appearance. Explanatory
matter and source notations for borrowed or adapted tables should be placed in a table footnote, not in the title or table body.
Figure legends
Figure legends should allow interpretation of the figures without reference to the text.
Figures
Figures—All figures must be cited in the text and numbered in order of appearance. Computer-generated figures should use solid
fills or cross-hatching, not tonal shading. Figure legends should be presented separately and placed in the manuscript after the list
of references. Figure legends should be brief and not repetitive of description in the text. Color figures may be accepted but any cost
related to reproduction is the responsibility of the author. However, color figures may be published in the electronic version of The
Journal at no cost to the authors. Authors should consult Elsevier's website for guidelines for preparing electronic artwork: http://www.authors.elsevier.com/artwork
Special sections in the Journal of Stroke and Cerebrovascular Diseases
Controversies: A Controversies
Section will appear several times yearly and serve as a medium for communicating controversy in the field of stroke and cerebrovascular
disease. Authors will be selected for their expertise or outspoken positions or for their objectivity and analysis of a chosen subject.
The Editor of the Controversy Section will oversee the preparation of the submitted manuscripts. They or an invited Guest Editor will
add their commentary.
Rapid Communications: The Editor will provide the most rapid turnaround time possible in the
review process. Authors may request rapid review of material found to be of critical importance to the field. The authors should accompany
their manuscript with a letter stating clearly why they consider their work is appropriate for that request. These manuscripts will be
published in the next subsequent issue of the Journal at the Editor's discretion.
Case Reports: Reports of clinical
interest should contain no more than 400 words of text and one table or figure. The reference list should be limited to 10. The authors
should also limit their case reports to new materials, rare clinical conditions, or cases that provide insight into controversial disease
states. They should provide their reason for the case report in a separate cover letter to the author.
Journal Club:
Journal Club will appear several times yearly. This section provides the opportunity for authors to publish journal clubs conducted in
their own institutions on articles of recent interest from peer-reviewed medical literature. The authors should review no more than two
articles and provide a summary of each article. This should be followed by their critical review of the paper, followed by the voiced
opinion of named commentators in the audience. The authors should then summarize their conclusions at the end of the article. This section
provides an opportunity for residents in training and students of clinical cerebrovascular disease to communicate their opinions of the
stroke literature.
Methodologic and Technical Reports: The Journal will accept the full description of clinical trials
prior to publication of results. The paper must include comprehensive details of the methodologic design. Publications are expected to
enhance the science of clinical trials design and to provide extensive detail of these methods. It is hoped that authors will follow
up with publication of some, if not, all aspects of the results of the clinical trial.
The Technical Note section will permit publication
of innovative techniques in neurology, neurosurgery, and interventional radiology as regards the stroke and cerebrovascular disease sciences.
The techniques should be novel and extensively described.
Editorial commentary
Every issue will be introduced by a
section in which Guest Editors will comment on papers in the current Journal. These articles will be summarized, highlighting items of
special interest. The commentary will discuss the importance of the paper and its relevance to the field. Controversial aspects of the
selected articles will be emphasized.
